212 related articles for article (PubMed ID: 22516952)
1. Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin.
Nijnik A; Pistolic J; Filewod NC; Hancock RE
J Innate Immun; 2012; 4(4):377-86. PubMed ID: 22516952
[TBL] [Abstract][Full Text] [Related]
2. The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells.
Nijnik A; Pistolic J; Cho P; Filewod NC; Falsafi R; Ramin A; Harder KW; Hancock RE
J Leukoc Biol; 2012 Apr; 91(4):599-607. PubMed ID: 22246800
[TBL] [Abstract][Full Text] [Related]
3. Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli.
Filewod NC; Pistolic J; Hancock RE
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):233-40. PubMed ID: 19527294
[TBL] [Abstract][Full Text] [Related]
4. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.
Niyonsaba F; Ushio H; Nagaoka I; Okumura K; Ogawa H
J Immunol; 2005 Aug; 175(3):1776-84. PubMed ID: 16034119
[TBL] [Abstract][Full Text] [Related]
5. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes.
Chen X; Takai T; Xie Y; Niyonsaba F; Okumura K; Ogawa H
Biochem Biophys Res Commun; 2013 Apr; 433(4):532-7. PubMed ID: 23524263
[TBL] [Abstract][Full Text] [Related]
6. Cathelicidin antimicrobial peptide LL-37 augments interferon-β expression and antiviral activity induced by double-stranded RNA in keratinocytes.
Takiguchi T; Morizane S; Yamamoto T; Kajita A; Ikeda K; Iwatsuki K
Br J Dermatol; 2014 Sep; 171(3):492-8. PubMed ID: 24601852
[TBL] [Abstract][Full Text] [Related]
7. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways.
Yu J; Mookherjee N; Wee K; Bowdish DM; Pistolic J; Li Y; Rehaume L; Hancock RE
J Immunol; 2007 Dec; 179(11):7684-91. PubMed ID: 18025214
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.
Braff MH; Hawkins MA; Di Nardo A; Lopez-Garcia B; Howell MD; Wong C; Lin K; Streib JE; Dorschner R; Leung DY; Gallo RL
J Immunol; 2005 Apr; 174(7):4271-8. PubMed ID: 15778390
[TBL] [Abstract][Full Text] [Related]
9. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway.
Pistolic J; Cosseau C; Li Y; Yu JJ; Filewod NC; Gellatly S; Rehaume LM; Bowdish DM; Hancock RE
J Innate Immun; 2009; 1(3):254-67. PubMed ID: 20375583
[TBL] [Abstract][Full Text] [Related]
10. PPARγ mediates innate immunity by regulating the 1α,25-dihydroxyvitamin D3 induced hBD-3 and cathelicidin in human keratinocytes.
Dai X; Sayama K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yang L; Hirakawa S; Hashimoto K
J Dermatol Sci; 2010 Dec; 60(3):179-86. PubMed ID: 20970965
[TBL] [Abstract][Full Text] [Related]
11. Cathelicidin LL-37 Activates Human Keratinocyte Autophagy through the P2X₇, Mechanistic Target of Rapamycin, and MAPK Pathways.
Ikutama R; Peng G; Tsukamoto S; Umehara Y; Trujillo-Paez JV; Yue H; Nguyen HLT; Takahashi M; Kageyama S; Komatsu M; Okumura K; Ogawa H; Ikeda S; Niyonsaba F
J Invest Dermatol; 2023 May; 143(5):751-761.e7. PubMed ID: 36455652
[TBL] [Abstract][Full Text] [Related]
12. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea.
Salzer S; Kresse S; Hirai Y; Koglin S; Reinholz M; Ruzicka T; Schauber J
J Dermatol Sci; 2014 Dec; 76(3):173-9. PubMed ID: 25306296
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the P2X7 purinergic receptor and c-Jun N-terminal and extracellular signal-regulated kinases in cyclooxygenase-2 and prostaglandin E2 induction by LL-37.
Chotjumlong P; Bolscher JG; Nazmi K; Reutrakul V; Supanchart C; Buranaphatthana W; Krisanaprakornkit S
J Innate Immun; 2013; 5(1):72-83. PubMed ID: 23095809
[TBL] [Abstract][Full Text] [Related]
14. Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation.
Choi KY; Napper S; Mookherjee N
Immunology; 2014 Sep; 143(1):68-80. PubMed ID: 24666281
[TBL] [Abstract][Full Text] [Related]
15. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
[TBL] [Abstract][Full Text] [Related]
16. Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.
Su W; Chen Y; Wang C; Ding X; Rwibasira G; Kong Y
Biochem Biophys Res Commun; 2016 Apr; 473(1):283-289. PubMed ID: 27012197
[TBL] [Abstract][Full Text] [Related]
17. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function.
Akiyama T; Niyonsaba F; Kiatsurayanon C; Nguyen TT; Ushio H; Fujimura T; Ueno T; Okumura K; Ogawa H; Ikeda S
J Innate Immun; 2014; 6(6):739-53. PubMed ID: 24862212
[TBL] [Abstract][Full Text] [Related]
18. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands.
Kandler K; Shaykhiev R; Kleemann P; Klescz F; Lohoff M; Vogelmeier C; Bals R
Int Immunol; 2006 Dec; 18(12):1729-36. PubMed ID: 17041145
[TBL] [Abstract][Full Text] [Related]
19. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes.
Bowdish DM; Davidson DJ; Speert DP; Hancock RE
J Immunol; 2004 Mar; 172(6):3758-65. PubMed ID: 15004180
[TBL] [Abstract][Full Text] [Related]
20. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes.
Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S
J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
